access | colab

top of page

Search

Apr 44 min read

The cost of inaction (on cancer)

Jun 6, 20235 min read

the true cost of the economic burden of cancer in canada

Mar 7, 20233 min read

Project Orbis. Accelerating time to patient access?

Nov 8, 202211 min read

the patented medicines review board has lost its way (again)

Nov 7, 20221 min read

open letter: let’s put cancer at the top of the agenda

May 25, 20223 min read

Cancer deaths must not be a side effect of the pandemic: delays in cancer diagnosis and treatment co

Nov 17, 20213 min read

why precision medicine matters

Nov 11, 20212 min read

the importance of biomarker testing

Nov 17, 20201 min read

improving access to innovative therapies

Feb 17, 20203 min read

#travelwithcolab

Sep 10, 20193 min read

if not now, when?

Sep 5, 20192 min read

car-t. one year later

Aug 29, 20192 min read

biosimilars are not just a cost saving opportunity but the opportunity to create a more sustainable

Aug 20, 20192 min read

managing expectations

Aug 1, 20192 min read

how car-t is an opportunity for canada

Jun 21, 20193 min read

biosimilars. the european experience

Mar 25, 20193 min read

challenges & potential barriers to CAR-T access

thecancercollaborative
lecollaboratoirecancer

@cancercolab

bottom of page